MARKET

SIBN

SIBN

Si-Bone
NASDAQ
14.27
-0.81
-5.37%
After Hours: 14.27 0 0.00% 16:20 04/25 EDT
OPEN
14.97
PREV CLOSE
15.08
HIGH
14.97
LOW
14.26
VOLUME
241.78K
TURNOVER
0
52 WEEK HIGH
29.51
52 WEEK LOW
14.26
MARKET CAP
585.99M
P/E (TTM)
-12.6541
1D
5D
1M
3M
1Y
5Y
Analysts’ Opinions Are Mixed on These Healthcare Stocks: SI-Bone (SIBN), Conmed (CNMD) and Chemed (CHE)
TipRanks · 22h ago
Ongoing Procedural Growth May Aid Stryker's (SYK) Q1 Earnings
NASDAQ · 1d ago
Is a Beat Likely for West Pharmaceutical (WST) in Q1 Earnings?
NASDAQ · 3d ago
Weekly Report: what happened at SIBN last week (0415-0419)?
Weekly Report · 3d ago
Notable Friday Option Activity: COIN, SIBN, DYN
NASDAQ · 6d ago
Is a Beat Likely for Edwards Lifesciences (EW) in Q1 Earnings?
NASDAQ · 04/17 15:01
Truist Financial Sticks to Their Buy Rating for SI-Bone (SIBN)
TipRanks · 04/17 08:02
Is a Beat Likely for Intuitive Surgical (ISRG) in Q1 Earnings?
NASDAQ · 04/16 18:04
More
About SIBN
SI-BONE, Inc. is a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy. The Company specializes in minimally invasive surgical implant systems to address sacroiliac joint dysfunction as well as address unmet clinical needs in pelvic fixation and management of pelvic fractures. The Company's products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products. Its products include iFuse, iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite. Within the United States, iFuse, iFuse-3D and iFuse-TORQ have clearances for applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma. Its first-generation iFuse, a machined triangular titanium implant, has a triangular cross section that resists twisting or rotation of the implant. The Company's second generation iFuse product, the iFuse-3D implant, is a patented titanium implant.

Webull offers SI-Bone Inc stock information, including NASDAQ: SIBN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SIBN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SIBN stock methods without spending real money on the virtual paper trading platform.